使用当前自动药敏试验系统检测对哌拉西林-他唑巴坦耐药/对泛β-内酰胺敏感的大肠埃希菌 - Suppr

Suppr

超能文献

Detection of Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli with Current Automated Susceptibility Test Systems.

作者信息

Monogue Marguerite L, Tanner Linda K, Brecher Stephen M, Aslanzadeh Jaber, Nicolau David P

机构信息

1Center for Anti-infective Research and Development,Hartford Hospital,Hartford,Connecticut.

2Department of Microbiology,Eastern Connecticut Health Network,Manchester,Connecticut.

出版信息

Infect Control Hosp Epidemiol. 2017 Mar;38(3):379-380. doi: 10.1017/ice.2016.325. Epub 2017 Jan 10.

DOI:10.1017/ice.2016.325

PMID:28069100

Abstract

摘要

相似文献

Detection of Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli with Current Automated Susceptibility Test Systems.使用当前自动药敏试验系统检测对哌拉西林-他唑巴坦耐药/对泛β-内酰胺敏感的大肠埃希菌

Infect Control Hosp Epidemiol. 2017 Mar;38(3):379-380. doi: 10.1017/ice.2016.325. Epub 2017 Jan 10.

Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.特征明确的产超广谱β-内酰胺酶（CTX-M）多重耐药大肠埃希菌的抗菌药敏性：自动化系统检测哌拉西林/他唑巴坦耐药性的失败

Int J Antimicrob Agents. 2008 Oct;32(4):333-8. doi: 10.1016/j.ijantimicag.2008.04.023. Epub 2008 Aug 12.

In the literature. Piperacillin-tazobactam and extended-spectrum β-lactamase--producing Escherichia coli.在文献中。哌拉西林-他唑巴坦与产超广谱β-内酰胺酶的大肠埃希菌。

Clin Infect Dis. 2013 Nov;57(10):iii-iv.

Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli.产CTX-M-15的大肠埃希菌对多利培南及他唑巴坦/哌拉西林产生体外耐药性风险的比较

J Infect Chemother. 2015 May;21(5):381-4. doi: 10.1016/j.jiac.2015.01.006. Epub 2015 Jan 23.

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.比较产超广谱β-内酰胺酶和不产超广谱β-内酰胺酶大肠埃希菌分离株的接种物效应对阿莫西林克拉维酸和哌拉西林他唑巴坦抗菌活性的影响。

Clin Microbiol Infect. 2010 Feb;16(2):132-6. doi: 10.1111/j.1469-0691.2009.02893.x. Epub 2009 Jul 15.

Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Klebsiella pneumoniae Strains.针对哌拉西林-他唑巴坦耐药/泛β-内酰胺敏感肺炎克雷伯菌菌株，人源化哌拉西林-他唑巴坦暴露的不一致性

Antimicrob Agents Chemother. 2017 Jun 27;61(7). doi: 10.1128/AAC.00491-17. Print 2017 Jul.

In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli.哌拉西林/他唑巴坦合剂对产 TEM 抑制剂耐药和复杂突变 TEM 的临床大肠埃希菌的体外疗效。

J Antimicrob Chemother. 2011 May;66(5):1052-6. doi: 10.1093/jac/dkr045. Epub 2011 Feb 28.

In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli.人源化哌拉西林-他唑巴坦暴露量与哌拉西林-他唑巴坦耐药/泛β-内酰胺敏感大肠埃希菌的体外-体内不一致性

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7527-7529. doi: 10.1128/AAC.01208-16. Print 2016 Dec.

Exploring the effectiveness of tazobactam against ceftazidime resistant Escherichia coli: insights from the comparison between susceptibility testing and beta-lactamase inhibition.探究他唑巴坦对头孢他啶耐药大肠杆菌的有效性：药敏试验与β-内酰胺酶抑制比较的见解

FEMS Microbiol Lett. 2004 May 1;234(1):99-103. doi: 10.1016/j.femsle.2004.03.025.

Point mutations in the inc antisense RNA gene are associated with increased plasmid copy number, expression of blaCMY-2 and resistance to piperacillin/tazobactam in Escherichia coli.反义 RNA 基因 inc 点突变与质粒拷贝数增加、blaCMY-2 表达和大肠埃希菌对哌拉西林/他唑巴坦的耐药性有关。

J Antimicrob Chemother. 2012 Feb;67(2):339-45. doi: 10.1093/jac/dkr479. Epub 2011 Nov 24.

引用本文的文献

Treatment of Piperacillin-Tazobactam-Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials.用碳青霉烯类药物与保留碳青霉烯类的抗菌药物治疗哌拉西林-他唑巴坦不敏感/头孢曲松敏感感染

Open Forum Infect Dis. 2023 Jun 8;10(6):ofad262. doi: 10.1093/ofid/ofad262. eCollection 2023 Jun.

Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant by the MALDIpiptaz test.MALDIpiptaz 试验对 ESRI 开发人员和哌拉西林/他唑巴坦耐药的超灵敏和快速鉴定。

Emerg Microbes Infect. 2022 Dec;11(1):2034-2044. doi: 10.1080/22221751.2022.2113746.

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla.产酸克雷伯菌中 IS26 介导 bla 基因扩增导致的哌拉西林/他唑巴坦耐药

Nat Commun. 2020 Oct 1;11(1):4915. doi: 10.1038/s41467-020-18668-2.

Epidemiology of Bloodstream Infections Caused by and That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible.由对哌拉西林 - 他唑巴坦不敏感但对头孢曲松敏感的[细菌名称未给出]引起的血流感染的流行病学

Open Forum Infect Dis. 2018 Nov 19;5(12):ofy300. doi: 10.1093/ofid/ofy300. eCollection 2018 Dec.

Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible : A Missed Opportunity for De-Escalation of Therapy.由哌拉西林/他唑巴坦不敏感、头孢菌素敏感引起的血流感染：治疗降阶梯的一个错失机会。

Antibiotics (Basel). 2018 Dec 1;7(4):104. doi: 10.3390/antibiotics7040104.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验